People · Operator
Named in public records as an officer, director or promoter · active 2011–2026 · Biotechnology, Other, Medical Devices, Other Health Care, Energy Conservation, Software / Tech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Immunic, Inc. | — | Biotechnology | Series D+ | $514.4M | $1.3B | 2022 |
| Classy Holdings, Inc. | — | Other | Series D+ | $104.5M | $1.6B | 2021 |
| Classy, Inc. | — | Other | Series B | $63.6M | $290.8M | 2015 |
| Envision Diagnostics, Inc. | — | Medical Devices | Series B | $29.6M | $625.0M | 2019 |
| Aai Holdings Corp. | — | Other Health Care | Series B | $20.0M | $443.1M | 2011 |
| Copper Labs, Inc | — | Energy Conservation | Seed | $8.6M | $8.1M | 2022 |
| IronCore Labs, Inc. | — | Software / Tech | Seed | $4.3M | $2.8M | 2017 |
| EagleHawk One, Inc. | — | Business Services | Pre-Seed | $2.2M | $2.0M | 2018 |
| Airsign, Inc. | — | Other | Pre-Seed | $1.3M | $3.5M | 2014 |
Patrick Walsh at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Patrick Walsh on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Howard Deshong | 2 | 3 |
| Paul Leggett | 2 | 3 |
| Scot Chisholm | 2 | 2 |
| Christopher Himes | 2 | 2 |
| Craig Cummings | 1 | 10 |
| Richard Harjes | 1 | 6 |
| Jason Mitchell | 1 | 4 |
| Charles Liamos | 1 | 4 |
| Lowell E. Sears | 1 | 4 |
| Trevor Thompson | 1 | 3 |
| Judson Valeski | 1 | 3 |
| Robert Hall | 1 | 3 |
| Muneer A. Satter | 1 | 3 |
| Ryan Martens | 1 | 2 |
| Ross A. Jaffe | 1 | 2 |
| Patrick J Welsh | 1 | 2 |
| Alan Heller | 1 | 2 |
| Brian Modiano | 1 | 2 |
| CAROLIN FUNK | 1 | 2 |
| Brian Hersman | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.